SIG Brokerage’s Vir Biotechnology VIR Stock Holding History

SIG Brokerage’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,375	Closed	-$74.6K	–	984
2025 Q4	$74.6K	Hold	12,375	–	–	﹤0.01%	640
2025 Q3	$70.7K	Hold	12,375	–	–	﹤0.01%	715
2025 Q2	$62.4K	Hold	12,375	–	–	﹤0.01%	665
2025 Q1	$80.2K	Buy	+12,375	New	+$110K	﹤0.01%	513

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

SIG Brokerage's VIR Position: Q1 2026 in Review

SIG Brokerage sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 12,375 shares — an estimated $74.6K sold.

SIG Brokerage first reported a position in VIR in Q1 2025 and held it in 4 quarters. The position peaked at $80.2K in Q1 2025. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

SIG Brokerage reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
SIG Brokerage sold 12,375 Vir Biotechnology shares in Q1 2026, an estimated $74.6K.
SIG Brokerage first reported a position in Vir Biotechnology in Q1 2025 and held it in 4 quarters.
SIG Brokerage's Vir Biotechnology position peaked at $80.2K in Q1 2025.
251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.